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Abstract Background: Fluid
challenges (FCs) are one of the most
commonly used therapies in critically
ill patients and represent the corner-
stone of hemodynamic management
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in intensive care units. There are clear
benefits and harms from fluid therapy.
Limited data on the indication, type,
amount and rate of an FC in critically
ill patients exist in the literature. The
primary aim was to evaluate how
physicians conduct FCs in terms of
type, volume, and rate of given fluid;
the secondary aim was to evaluate
variables used to trigger an FC and to
compare the proportion of patients
receiving further fluid administration
based on the response to the FC.
Methods: This was an observational
study conducted in ICUs around the
world. Each participating unit entered
a maximum of 20 patients with one
FC. Results: 2213 patients were
enrolled and analyzed in the study.
The median [interquartile range]
amount of fluid given during an FC
was 500 ml (500–1000). The median
time was 24 min (40–60 min), and
the median rate of FC was 1000
[500–1333] ml/h. The main indica-
tion for FC was hypotension in 1211
(59 %, CI 57–61 %). In 43 % (CI
41–45 %) of the cases no hemody-
namic variable was used. Static
markers of preload were used in 785
of 2213 cases (36 %, CI 34–37 %).
Dynamic indices of preload respon-
siveness were used in 483 of 2213
cases (22 %, CI 20–24 %). No safety
variable for the FC was used in 72 %
(CI 70–74 %) of the cases. There was
no statistically significant difference
in the proportion of patients who
received further fluids after the FC
between those with a positive, with an
uncertain or with a negatively judged
response. Conclusions: The current
practice and evaluation of FC in
critically ill patients are highly vari-
able. Prediction of fluid
responsiveness is not used routinely,
safety limits are rarely used, and
information from previous failed FCs
is not always taken into account.
Introduction
Many liters of intravenous fluids are used per year to treat
critically ill patients worldwide. Fluids are one of the most
commonly used therapies in critically ill patients and rep-
resent the cornerstone of hemodynamic management in
intensive care units (ICUs) [1]. The basic physiological
target of administration of fluids is to improve tissue perfu-
sion. Hemodynamic optimization with fluids has been shown
to improve patient outcome when applied in the periopera-
tive period and in the early phases of sepsis [1–4]. Timing of
the intervention is important; in the context of shock, higher
fluid administration in the first 3 h was associated with better
outcome in a retrospective study [5]. On the other hand,
liberal administration of fluids may lead to a positive fluid
balance [6] which is independently associated with a poor
outcome [7]. Accordingly, in patients with respiratory fail-
ure, once hemodynamically stable, fluid restriction is
associated with earlier weaning from mechanical ventilation
[8].
Altogether, it seems reasonable to give the needed
amount of fluids when hemodynamically patients are
unstable and to restrict fluids when they are stabilized.
Such an approach makes physiological sense and in the-
ory should bring better outcomes to the patients. Whereas
in overt bleeding, fluids are often given without guidance
with specific hemodynamic monitoring, in other condi-
tions, when hypovolemia may be subtler or when the
response to fluids is more variable, fluids may be given on
the basis of monitoring their hemodynamic impact. This
practice, the ‘‘fluid challenge’’ technique (FC) was pro-
posed more than 30 years ago [9–11]. Over recent
decades new techniques have been developed in order to
monitor and predict the response to fluids. The roles of
static markers of preload such as central venous pressure
(CVP) and pulmonary artery occlusion pressure (PAOP)
have been questioned and dynamic indices of preload
have been studied [12–14]. The use of dynamic indices is
now recommended [4] but many technical limitations
may preclude their use.
However, no data exist on the manner in which FCs
are indicated and performed in critically ill patients
around the globe. We conducted a multicenter interna-
tional observational study aiming to evaluate the
indications, current practice, and judgment of benefit of
FCs in critical care settings. We hypothesized that there is
an extensive variation in the current practice of FC.
Methods
This was an observational study conducted by the ESICM
Trials Group (17–23 April 2013 or 23–29 May 2013) and
registered on ClinicalTrials.Gov (NCT01787071). ICUs
were able to enter the study in one of the 2 weeks. The
possibility to choose between 2 weeks was chosen in order
to compensate for differences in national holidays in dif-
ferent countries and therefore to maximize the recruitment
of study units. IRB approval was obtained in each country
and the local investigators were responsible to ensure that
with local and national requirements were fulfilled. In most
participating countries informed consent from the patient
was waived owing to the observational study design.
National coordinators and local investigators are listed in
the electronic supplementary material (ESM).
We included all consecutive adult (18 years old and
above) patients, up to a maximum of 20 per participating
unit, in whom an FC was performed during a 1-week period.
FC was defined as administration of any bolus of fluid
(crystalloid or colloid) in less than 2 h. Administration of
red blood cells or fresh frozen plasma was not considered as
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an FC. The exclusion criteria were previous inclusion in the
study, overt bleeding, and time of an FC exceeding
120 min. Only one FC, ideally the first, was considered for
each patient. Only one FC per patient was recorded.
We collected data on patient demographics, indica-
tions for the FC, the type, amount, and rate of fluids
administered, available hemodynamic variables, and
judgment on the efficacy and safety of the FC. The case
report form (CRF) is available in the ESM. Anonymous
CRF data were uploaded by local investigators using a
Web-based electronic CRF (Clinfile, Sevres, France). The
data were stored securely in a server located in Brussels.
All procedures regarding data management complied with
the EU directive on data protection (95/46/EC).
Study aims
The primary aim of this study was to evaluate how
physicians indicate FC.
The secondary aims were
– to evaluate the type, volume, and rate of fluid
administered during an FC.
– to evaluate variables used to trigger/indicate an FC, and
to judge the effect or safety of an FC.
– to compare the proportion of patients receiving further
fluid administration based on the response to the fluid
challenge, as judged by the bedside clinician after a
fluid challenge.
Statistical analysis
Categorical variables are described as numbers (percent-
ages) and continuous variables as mean (±standard
deviation), if normally distributed, or median [interquar-
tile range] if not normally distributed. The paired t test or
Wilcoxon test was used to compare hemodynamic vari-
ables after the FC with baseline, when applicable.
Proportions of patients were compared with v2 test and
data presented as proportions and odd ratios. A p value of
less than 0.05 was considered statistically significant. We
targeted a minimum of 100 study sites with a maximum
of 20 FCs each and a minimum of 1000 patients.
Results
We included 2279 patients with an FC from 311 centers
across 46 countries (ESM). Of those 2279, 66 patients
were excluded from the analysis as a result of at least one
exclusion criterion (see the study flow chart, Fig. 1 ESM).
A total of 2213 patients were analyzed.
Data on demographic factors and concomitant treat-
ment are presented in Table 1. The main diagnostic
groups were sepsis (n = 595, 27.0 % [CI 25.2–28.9 %]),
cardiac (n = 454, 20.6 % [CI 18.9–22.3 %]), and respi-
ratory failure (n = 238, 10.8 % [CI 9.5–12.1 %]).
The median amount of fluid given during an FC was
500 ml [500–1000]. The median time was 24 min
[40–60 min], and the median rate of fluid administration
was 1000 [500–1333] ml/h. Crystalloids were the most
used (in 74.0 % [CI 72.2–75.8 %] of the cases) including
normal saline in 45.9 % [CI 25.2–28.9 %], and balanced
solutions were used in 53.5 % [CI 51.4–55.6 %] of FCs
(Table 2).
The main indication for fluid administration was
hypotension in 1211 (58.7 % [CI 56.7–60.1 %]) of FCs.
In 42.7 % [CI 40.6–44.8 %] of the cases no hemodynamic
variable was used to predict fluid responsiveness. Static
markers of preload were used in 785 of 2213 cases
(35.5 % [CI 33.5–37.5 %]). In 572 of 785 of these cases
(89.9 % [CI 87.8–92.0 %]) CVP was the leading variable
used (25.8 % [CI 24.0–27.6 %] of all FCs). Dynamic
indices of preload responsiveness were used in 483 of
2213 cases (21.9 % [CI 20.2–23.6 %]). In 238 of those
483 cases (49.3 % [CI 44.8–53.8 %]) passive leg raising
(PLR) was the leading variable (10.7 % [CI 9.4–12.0 %]
of all FCs) (Table 3).
The response to fluid administration was judged as
positive in 1544 of 2213 (69.8 % [CI 67.9–71.7 %]) of
the FCs, most often as an increase in arterial blood
pressure (1039 of 1544, 67.3 % [CI 65.0–69.7 %]). No
safety variable for the FC was used in 72.0 % [CI
70.1–73.9 %] of the cases. When used, CVP was the most
common variable (57 %). Further fluids were adminis-
tered in 1050 of 2213 (49.8 % [CI 47.7–51.9 %]) of the
cases. The proportion of patients who received further
fluids after was similar in patients with a positive
(47.9 ± 2.5 %), with an uncertain [52.4 ± 7.1 %, OR
0.94 (0.76–1.16)] or with a negatively judged response to
FC [49.4 ± 6.6 %, OR 0.83 (0.62–1.13)] (p = 0.46 by v2
test) (Fig. 1).
Discussion
The two major findings of this large global multicenter
observational study comprising 2213 patients are first a
significant variability in the conduction of FC and second
the fact that the response to the initial FC does not have an
impact when prescribing further fluid administration.
These findings were observed in critically ill patients all
around the world. All aspects of the FC, the type, volume,
and rate of given fluids, and more importantly the indi-
cation, evaluation of possible benefit, and safety variables
used varied significantly. It is possible that some of the
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variability may be explained by variables not collected in
our study, such as unit policies and protocols.
While we recorded only one FC per patient, we also
recorded the decision for further fluid administration post
FC. When looking at the response to fluid administration,
investigators found a positive response only in seven
cases out of ten. However, further fluids were given in
comparable proportions of patients despite the initial
response. If an FC is used to look at a dynamic response
and to decide whether further fluids may be administered
safely, one would expect that further fluids should be
administered only in patients with a positive initial
response. In our study the response to the initial fluid
challenge made no difference to the decision for further
fluid administration. This behavior seems to be harmful
and highlights a huge need for education.
This huge variability in the current practice regarding
an FC may reflect the presence of controversies in current
guidelines. In the Surviving Sepsis Guidelines fluids are
recommended in the very early phase of hemodynamic
resuscitation of patients with severe sepsis [15]. In this case
a fluid bolus is considered as administration of fluids of
30 ml/kg. In high-risk surgical patients fluid challenges are
often given in smaller amounts [11]. In the perioperative
setting there are guidelines covering the administration of
fluids recommending the use of fluids for stroke volume
optimization [16]. While it is true that different conditions
may require different techniques, our data show extensive
variability even within the same clinical condition.
Simple clinical signs led to FC in more than 80 %
patients (hypotension, 58.7 %; oliguria, 18 %; or weaning of
vasopressors, 7.1 %). Of note, markers of inadequate tissue
perfusion such as lactate or skin mottling were used as an
indication for an FC only in less than 8 % of the cases. This
seems paradoxical since fluids are mostly indicated to
increase cardiac output [11, 17, 18] and tissue perfusion [19].
Moreover, some studies focused on microcirculation clearly
showed that clinical signs cannot predict microcirculatory
Table 1 Baseline
characteristics and
concomitant treatments in
critically ill patients
(N = 2213)
Age (years) 63 ± 16
Female sex 824 (37.3 [35.3–39.3])
Reason for admission to ICU [n (%)]
Medical 962 (43.5 [41.4–45.6])
Surgical 691 (31.2 [29.3–33.1])
Emergency surgical 548 (24.8 [23.0–26.6])
Main diagnosis
Sepsis 595 (27.0 [25.2–28.9])
Cardiac 454 (20.6 [18.9–22.3])
Respiratory 238 (10.8 [9.5–12.1])
Neurologic 180 (8.2 [7.1–9.3])
Trauma 141 (6.4 [5.4–7.4])
Intoxication 41 (1.9 [1.3–2.5])
Other 558 (25.3 [23.5–27.1])
SOFA score 7 [4–10]
Physiological variables
HR (bpm) 95 ± 24
MAP (mmHg) 70 ± 16
CVP (mmHg) 8 ± 5
Urine output (ml/h) 40 [20–80]
Fluid balance previous 24 h (ml) 2698 [1500–3945]
Lactate (mmol/L) 1.8 [1.1–2.9]
Vasopressor/inotropic agents
Dopamine (n (%); lg/kg min) 91 (4); 5 [4–10]
Norepinephrine (n (%); lg/kg min) 903 (41); 0.16 [0.07–0.34]
Epinephrine (n (%); lg/kg min) 74 (3); 0.1[0.03–0.30]
Dobutamine (n (%); lg/kg min) 159 (7); 4 [3–5]
Mechanical ventilation, n (%) of 2172
None 736 (33.8 [31.8–35.8])
Noninvasive ventilation 64 (2.9 [2.2–3.6])
Invasive mechanical ventilation 1372 (63.1 [61.1–65.1])
Characteristics of patients under invasive mechanical ventilation n (%) of 1372
Sedation present 927 (67.6 [65.1–70.1])
Spontaneous ventilation included 602 (43.8 [41.2–46.4])
Renal replacement therapy, n (%) of 2087
None 1930 (92.5 [91.4–93.6])
Dialysis 58 (2.8 [2.1–3.5])
Hemofiltration 99 (4.7 [3.8–5.6])
Qualitative data are given as absolute number (percentage); quantitative data are given as median
value [interquartile range]
HR heart rate, MAP mean arterial pressure, CVP central venous pressure, CVVH continuous veno-
venous hemofiltration
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impairment [20] and that improving MAP and diuresis is not
sufficient for improving patient outcome [21–23].
These findings are in line with the ones published by
Boulain and coauthors [24]. In their study, limited to
ICUs in France, low blood pressure and low urine output
were the most used triggers for fluid administration. The
wider scope of our study demonstrates that this is com-
mon practice around the globe. It is interesting that so
much attention is paid to the blood pressure at the bed-
side. This variable is the most used both for triggering and
assessing the response to an FC. It is possible that the goal
of many clinicians is the one of increasing BP with an FC.
On the other hand it is possible that arterial blood pressure
was used as a surrogate of cardiac output (CO). This
seems common practice despite the known limitations of
this variable when used to estimate CO. The increase in
arterial pressure during an FC for instance is variable and
depends on vascular tone and arterial elastance [25]. In
patients increasing their CO in response to fluids, arterial
blood pressure increases only in those with high arterial
elastance [26, 27]. In summary, while fluids are mostly
indicated to increase cardiac output [11, 17, 18] and tissue
Table 2 Fluid challenge (N = 2213) characteristics
Volume (ml), median [IQR] 500 [500–999]
Rate (ml/h), median [IQR] 1000 [500–1333]
Type of fluids n % Of category % All fluids
Crystalloids 1713 74.3 [72.5–76.1]
NaCl 0.9 % 786 45.9 [43.5–48.3] 34.1 [32.1–36.1]
Balanced 916 53.5 [51.1–55.9] 39.8 [37.8–41.8]
G5 % DW 4 0.2 [0.0–0.4] 0.2 [0.0–0.4]
G5 % NaCl 0.45 % 7 0.4 [0.1–0.7] 0.3 [0.1–0.5]
Colloids 591 25.6 [23.8–27.4]
HES 249 42.1 [38.1–46.1] 10.8 [9.5–12.1]
Albumin 4–5 % 101 17.1 [14.1–20.1] 4.3 [3.5–5.2]
Gelatin 203 34.3 [30.5–38.1] 8.8 [7.6–10.0]
Dextran 13 2.2 [1.0–3.4] 0.5 [0.2–0.8]
Albumin 20 % 25 4.2 [2.6–5.8] 1.1 [0.7–1.5]
NaCl saline, balanced crystalloids with chloride concentration lower than saline (i.e., Plasma Lyte, Hartman’s), G5 % glucose 5 %, DW
dextrose in water, HES hydroxyethyl starch
Table 3 Indications and variables used to predict fluid responsiveness (N = 2213)
Indication n (%)
Hypotension 1211 (58.7 [56.7–60.8])
Weaning vasopressor 146 (7.1 [6.0–8.2])
Cardiac output 62 (3.0) [2.3–3.7]
Oliguria 372 (18.0 [16.4–19.6])
Skin mottling 36 (1.7 [1.2–2.2])
Lactate 128 (6.2 [5.2–7.2])
SvO2/ScvO2 10 (0.5 [0.2–0.8])
SVV/PPV 37 (1.8 [1.3–2.4])
CVP/PAOP 60 (2.9 [2.2–3.6])
Hemodynamic variable used to predict fluid responsiveness n % Of category % All
No variable used 945 42.7 [40.6–44.8]
Any variable used 1268 57.3 [55.2–59.4]
Static 785 35.5 [33.5–37.5]
CVP 572 89.9 [87.8–92.0] 25.8 [24.0–27.6]
PAOP 31 4.9 [3.4–6.4] 1.4 [0.9–1.9]
GEDVI 33 5.2 [3.6–6.8] 1.5 [1.0–2.0]
Other 149 23.4 [20.4–26.4] 6.7 [5.7–7.8]
Dynamic 483 21.9 [20.2–23.6]
PPV 88 18.2 [14.8–21.6] 4.0 [3.2–4.8]
SVV 88 18.2 [14.8–21.6] 4.0 [3.2–4.8]
PPV ? SVV 24 5.0 [3.1–6.9] 1.1 [0.7–1.5]
PLR 238 49.3 [44.8–53.8] 10.7 [9.4–12.0]
Echo variables 45 9.3 [6.7–11.9] 2.0 [1.4–2.6]
SvO2 mixed venous oxygen saturation, ScvO2 central venous oxy-
gen saturation, SVV stroke volume variation, PPV pulse pressure
variation, CVP central venous pressure, PAOP pulmonary artery
occlusion pressure, GEDVI global end diastolic volume, PLR pas-
sive leg raising, Echo echocardiography
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perfusion [19] and not to just to increase blood pressure,
at the bedside clinicians rely heavily on this variable both
to predict and assess fluid responsiveness (Table 4).
Importantly, in almost half of the patients no hemo-
dynamic variable was used to predict fluid
responsiveness—and if used CVP was used most often.
This is interesting considering that the CVP is a poor
variable to predict fluid responsiveness [12, 14, 28].
The use of dynamic indices of preload was infrequent
in our study. Cyclical changes in stroke volume (stroke
volume variation, SVV) and pulse pressure (pulse pres-
sure variation, PPV) during mechanical ventilation have
been shown to predict fluid responsiveness with high
sensitivity and specificity [29]. However, one of the
limitations is that the patient has to be in controlled
ventilation with tidal volumes equal to or higher than
8 ml/kg of ideal body weight [30], and with no arrhyth-
mias. It is possible that the limited use of these three
dynamic indices (in total 9 % of patients) was influenced
by a high prevalence of patients with preserved sponta-
neous breathing activity. Another possible explanation is
that we encouraged investigators to look at the first fluid
challenge in our study. In this case flow monitors may
have not have been in place yet. In this scenario though,
we would have expected a more prevalent use of
echocardiography. Of note, this was used to indicate FC
in only 2 % of the patients.
Passive leg rising is a maneuver that produces an
autologous fluid challenge by shifting venous blood from
the legs to the intrathoracic compartment. The response
measured by a flow monitor is able to predict the
response to a fluid challenge. This has been studied and
validated with different flow monitors. With a lower
degree of accuracy with respect to cardiac output and
stroke volume, blood pressure monitoring could be used
for this technique, too [31]. Considering that an increase
in blood pressure was used as the positive indicator of a
fluid challenge in two-thirds of the cases, our data
suggest that arterial pressure is the hemodynamic vari-
able on which the majority of clinicians focus.
Hypotension and weaning of vasopressor were the main
indications to give an FC and the response in arterial
pressure was the most used one for evaluation of pos-
sible benefit.
Our findings highlight a possible safety problem. Half
of the patients with a negative response received further
fluids. Of note, in three out four cases no safety limits
were used at all. While CVP is a poor marker of preload
and fluid responsiveness, it is one of the regulating
functions of the venous return and a raise in CVP may be
used as a safety limit [9, 32–34]. Given this finding and
that patients received further fluids despite no response to
the initial FC, the current practice and evaluation of FC
and fluid administration in critically ill patients seems to
be arbitrary, not evidence-based and possibly harmful.
We also found a high variability in the type of fluid
used with higher use of crystalloids compared to colloids.
It is difficult to interpret these results, since this study was
performed during a time of high debate among intensive
care clinicians following the publication of large
Further fluid administration – n (%) 1050 (47.4 ± 2.5) 
with an initial positive response n (%) OR 739 (47.9 ± 2.5)        Ref 
with an initial negative response n (%) OR 212 (49.4 ± 6.6)        OR 0.94 (0.76-1.16) 
with an initial uncertain response n (%) OR 99 (52.4 ± 7.1)          OR 0.83 (0.62-1.13) 
Fig. 1 Further fluid
administration post fluid
challenge
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randomized controlled trials advocating the use of crys-
talloids versus colloids [1, 35–38].
Our study has some obvious strengths. First, to the best
of our knowledge this study is the largest prospective
observational study investigating FCs in critically ill
patients and thus provides a reasonably exact estimate of
the current practice of the FCs given. Second, the inter-
national multicenter design limiting the cases from
individual sites increases its external validity. However,
there are several limitations of our study to be considered.
First, we recorded only when FCs were given and not when
FCs were not given. Thus, in practice we may have
underestimated the times when variables used to predict
fluid responsiveness were used. Second, we encouraged
investigators to record data on the first fluid challenge,
which may have several implications. At early stages, a
positive response to fluids is more likely and patients are
often less invasively monitored. Studying patients at later
stages may have yielded different results. Third, we
allowed a wide range of options (volume, type of fluid, first
or subsequent FC) to be recorded during an FC. It is pos-
sible that some investigators considered an FC what would
be normally defined a more sustained volume expansion.
We conclude that the current practice and evaluation
of FC in critically ill patients seems to be arbitrary.
While not demonstrable in this observational study, this
practice does not seem evidence-based and could be
harmful.
Our findings highlight an urgent need for more edu-
cational activities and more research to assess whether a
more standardized approach to a fluid challenge could
lead to better patient-centered outcomes.
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Table 4 Judged response to
fluid challenge Response classification [no. (%) of 2162]
Negative response 429 (19.8 [18.1–21.5])
Positive response 1544 (71.4 [69.5–71.4])
Uncertain 189 (8.7 [7.5–9.9])
Variable use to evaluate response [no. (%)
of 1544 with positive response]
Increase in BP 1039 (67.3 [65.0–69.7])
Decrease vasopressors 56 (3.6 [2.7–4.5])
Increase in CO 174 (11.3 [9.7–12.9])
Increase in SV 100 (6.5 [5.3–7.7])
Decrease in HR 374 (24.2 [22.1–26.3])
Urine output 590 (38.2 [35.8–40.6])
Lactate 281 (18.2 [16.3–20.1])
Skin perfusion 128 (8.3 [6.9–9.7])
Mental state 40 (2.6 [1.8–3.4])
ScvO2/SvO2 77 (5.0 [3.9–6.1])
SVV/PPV 110 (7.1 [5.8–8.4])
CVP/PAOP 256 (16.6 [14.7–18.5])
Other 132 (8.5 [7.1–9.9])
Safety limit used [no. (%) of 2213] 577 (27.9 [25.7–30.1])
Variable used in the safety limit group [no. (%) of 577]
CVP 329 (57.0 [53.0–61.0])
PAOP 39 (6.7 [4.7–8.8])
GEDVI 11 (1.9 [4.7–8.8])
EVLWI 28 (4.9 [3.1–6.7])
SpO2/SaO2 105 (18.2 [15.1–21.35])
CO 8 (1.4 [0.4–2.4])
SVV/PPV 80 (13.9 [11.1–16.7])
Other 120 (20.8 [17.5–24.1])
BP blood pressure, CO cardiac output, SV stroke volume, HR heart rate, SvO2 mixed venous oxygen
saturation, ScvO2 central venous oxygen saturation, SVV stroke volume variation, PPV pulse pressure
variation, CVP central venous pressure, PAOP pulmonary artery occlusion pressure, GEDVI global
end diastolic volume, EVLWI extravascular lung water index
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